VEGFA and Atrophy: report that on discontinuing intravitreal anti-VEGF treatment, no further amnesia developed and that cranial MRI two years after the first intravitreal anti-VEGF exposure did not show any significant differences compared to before treatment, presumably in terms of atrophy (a detailed description of the results was not available).